Description
GLP-1/glucagon dual receptor agonist developed for obesity and NASH. Strong clinical pipeline in Asia.
GLP-1/glucagon dual receptor agonist developed for obesity and NASH. Strong clinical pipeline in Asia.
GLP-1/glucagon dual receptor agonist developed for obesity and NASH. Strong clinical pipeline in Asia.
Reviews
There are no reviews yet.